US investor takes stake in Sensyne Health

By
Maria Davies
-
Sensyne Health CEO Paul Drayson
Paul Drayson, CEO, Sensyne Health

Nasdaq-listed technology investor Acacia Research Corporation has acquired an 11.8% stake in UK-based clinical AI company Sensyne Health. Precise terms of the deal have not…

You must be a HM Subscriber to view this content.

Subscribe Now »

RELATED ARTICLESMORE FROM AUTHOR